A carregar...

Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer

Over the last 20 years, median survival for patients with metastatic colorectal cancer (CRC) has remarkably improved from about 12 to over 30 months, mainly because of the development of new agents and patient selection using predictive biomarkers. However, the identification of the most effective t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Surg Oncol
Main Authors: Miyamoto, Yuji, Zhang, Wu, Lenz, Heinz-Josef
Formato: Artigo
Idioma:Inglês
Publicado em: Springer India 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705494/
https://ncbi.nlm.nih.gov/pubmed/29203992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13193-016-0543-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!